JP2011528718A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528718A5
JP2011528718A5 JP2011520127A JP2011520127A JP2011528718A5 JP 2011528718 A5 JP2011528718 A5 JP 2011528718A5 JP 2011520127 A JP2011520127 A JP 2011520127A JP 2011520127 A JP2011520127 A JP 2011520127A JP 2011528718 A5 JP2011528718 A5 JP 2011528718A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
condition
disease
pain
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011520127A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727374B2 (ja
JP2011528718A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/051200 external-priority patent/WO2010011619A1/en
Publication of JP2011528718A publication Critical patent/JP2011528718A/ja
Publication of JP2011528718A5 publication Critical patent/JP2011528718A5/ja
Application granted granted Critical
Publication of JP5727374B2 publication Critical patent/JP5727374B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011520127A 2008-07-21 2009-07-21 大型置換基を有する非フェノール性アミンオピオイド Active JP5727374B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8225508P 2008-07-21 2008-07-21
US61/082,255 2008-07-21
PCT/US2009/051200 WO2010011619A1 (en) 2008-07-21 2009-07-21 Large substituent, non-phenolic amine opioids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014204620A Division JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Publications (3)

Publication Number Publication Date
JP2011528718A JP2011528718A (ja) 2011-11-24
JP2011528718A5 true JP2011528718A5 (enExample) 2012-01-12
JP5727374B2 JP5727374B2 (ja) 2015-06-03

Family

ID=41137538

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011520127A Active JP5727374B2 (ja) 2008-07-21 2009-07-21 大型置換基を有する非フェノール性アミンオピオイド
JP2014204620A Pending JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014204620A Pending JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Country Status (7)

Country Link
US (1) US20100190817A1 (enExample)
EP (1) EP2318372B9 (enExample)
JP (2) JP5727374B2 (enExample)
AU (1) AU2009274147B2 (enExample)
CA (1) CA2731429C (enExample)
ES (1) ES2534055T3 (enExample)
WO (1) WO2010011619A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009274147B2 (en) * 2008-07-21 2014-09-04 Rensselaer Polytechnic Institute Large substituent, non-phenolic amine opioids
HRP20191029T1 (hr) 2009-12-04 2019-09-20 Alkermes Pharma Ireland Limited Derivati morfinana radi liječenja predoziranja lijekom
ES2582306T3 (es) 2010-03-22 2016-09-12 Rensselaer Polytechnic Institute Derivados de morfinano que contienen un grupo carboxamida como ligandos de receptores opioides
HRP20240109T1 (hr) 2010-08-23 2024-03-29 Alkermes Pharma Ireland Limited Postupci za liječenje povećanja tjelesne težine induciranog antipsihoticima
AU2012275181B2 (en) * 2011-06-29 2016-04-07 Alkermes, Inc. Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
EP3003311A2 (en) 2013-05-24 2016-04-13 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
JP2016519161A (ja) 2013-05-24 2016-06-30 アルカームス ファーマ アイルランド リミテッド モルファン及びモルフィナン類似物及び使用の方法
EP4243768A1 (en) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60109960T2 (de) * 2000-10-31 2006-02-16 Rensselaer Polytechnic Institute 8-substituierte 2,6-methano-3-benzazocine und 3-substituierte morphinane als opioidrezeptorbindende agenzien
WO2004007449A1 (en) * 2002-07-16 2004-01-22 Rensselaer Polytechnic Institute Process for conversion of phenols to carboxamides via the succinimide esters
ES2480390T3 (es) * 2005-07-21 2014-07-28 Rensselaer Polytechnic Institute 2,6-metano-3-benzazocinas 8-carboxamido sustituidas y morfanos 3-carboxamido sustituidos como ligandos de los receptores opioides
AU2009274147B2 (en) * 2008-07-21 2014-09-04 Rensselaer Polytechnic Institute Large substituent, non-phenolic amine opioids

Similar Documents

Publication Publication Date Title
JP2011528718A5 (enExample)
JP2010535814A5 (enExample)
WO2007122581A3 (en) Compositions and kits of phenylephrine
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
NZ592723A (en) Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
WO2011094337A8 (en) Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
IL203901A (en) Opioid-controlled controlled-release drug - with high alcohol resistance, process, preparation and use
CL2008001125A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
CL2008001126A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
WO2008122966A3 (en) A pharmaceutical composition of tacrolimus
WO2009121945A3 (en) Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
PH12013502674A1 (en) Compounds for the treatment of addiction
CL2007003765A1 (es) Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias.
WO2007050802A3 (en) Novel opioid antagonists
CL2007002958A1 (es) Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
EA200870449A1 (ru) Лечение воспалительных и язвенных заболеваний кишечника опиоидными антагонистами
EP2257543A4 (en) MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, PROCESSING METHODS AND PREPARATION METHODS THEREOF
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
MX2009008363A (es) Combinacion de un antagonista de receptor muscarinico y un agonista de receptor adrenergico beta 2.
JP2010508310A5 (enExample)
WO2014008351A3 (en) Andrographis paniculata compositions and methods for treatment of addictions
CL2008001563A1 (es) Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.
WO2007097770A8 (en) Metoprolol succinate e.r. tablets and methods for their preparation
WO2008154234A3 (en) Extended release formulation of nevirapine